Riskpilot← Back to searchSign inGet full accessCLEVER CEUTICALS ApS
APSActiveCVR 32330304Holmevej 34Wholesale of other intermediate products · NACE 4686Est. 2011— employeeswww.sprunk-jansen.com
Revenue 2025
DKK 0
EBITDA margin
—
-105% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
DKK 20K
+38% vs 2024
| Revenue | DKK 0 | — |
| EBITDA | DKK -885 | -105% |
| Net profit | DKK 20K | +38% |
| Total assets | DKK 449K | +5% |
| Equity | DKK 448K | +5% |
| Employees | — | — |
Legal name
CLEVER CEUTICALS ApS
CVR number
32330304
Legal form
Anpartsselskab
NACE code
4686 · Wholesale of other intermediate products
Founded
11. februar 2011
Share capital
DKK 100.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er at udøve konsulentvirksomhed og erhvervsmæssig virksomhed med service, handel, import og eksport samt aktiviteter i tilknytning hertil.
Address
Holmevej 34
Phone
+4540328488
Email
jk@cleverceuticals.dk
Website
www.sprunk-jansen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -286 | 25 | 59 | 866 | -320 | -39 | 133 | 58 | 44 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -286 | 25 | 59 | 866 | -320 | -39 | 133 | 58 | 18 | -1 | -0 | -0 | -0 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -286 | 25 | 59 | 866 | -320 | -39 | 133 | 58 | 18 | -1 | -0 | -0 | -0 | -1 |
| Net financials | -32 | -17 | -27 | -11 | -1 | -5 | -2 | -1 | -2 | 13 | 14 | 19 | 20 | 21 |
| Profit before tax | -319 | 8 | 32 | 855 | -321 | -44 | 131 | 56 | 16 | 12 | 14 | 18 | 19 | 20 |
| Tax | -0 | -0 | -0 | 136 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 5 | -0 |
| Net profit | -319 | 8 | 32 | 720 | -321 | -44 | 131 | 56 | 16 | 12 | 14 | 18 | 14 | 20 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 77 | 94 | 144 | 777 | 358 | 221 | 340 | 370 | 372 | 381 | 396 | 414 | 429 | 449 |
| Equity | -219 | -211 | -179 | 541 | 210 | 166 | 298 | 354 | 370 | 381 | 395 | 414 | 428 | 448 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 296 | 304 | 323 | 236 | 148 | 55 | 43 | 16 | 2 | 0 | 0 | 0 | 0 | 1 |
| Total debt | 296 | 304 | 323 | 236 | 148 | 55 | 43 | 16 | 2 | 0 | 0 | 0 | 0 | 1 |
EBITDA margin
-88500.0%
This company
15.8%
Market median
-560227% vs market
20122025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20122025
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20122025
Net profit margin
2000100.0%
This company
8.1%
Market median
+24692493% vs market
20122025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-02-11 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RS Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairman | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KINDEM & CO. ApS | Company | 50.0% | 50.0% | 2011 |
KRARUP ApS | Company | 33.3% | 33.3% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KINDEM & CO. ApS
CLEVER CEUTICALS ApS Board members of CLEVER CEUTICALS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Randi Sprunk-Jansen | Management | 0 companies |
| Jesper Krarup | Board of Directors | 0 companies |
| Erik Sprunk-Jansen | Chairman | 0 companies |